Barchart.com
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Pure Bioscience (PURE)

Pure Bioscience (PURE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0600 -0.0050 (-7.69%) 04/24/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0600 unch (unch) 15:10 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results Business Wire - Fri Mar 17, 2023

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0600 (-7.69%)
PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results Business Wire - Wed Dec 14, 2022

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0600 (-7.69%)
PURE Bioscience Reports Fiscal 2022 Financial Results Business Wire - Fri Oct 28, 2022

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0600 (-7.69%)
PURE Bioscience Reports Fiscal 2022 Third Quarter and Nine-Month Financial Results Business Wire - Tue Jun 14, 2022

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal third quarter and nine-month period...

PURE : 0.0600 (-7.69%)
PURE Bioscience Reports Fiscal 2022 Second Quarter And Six-Month Financial Results Business Wire - Tue Mar 15, 2022

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0600 (-7.69%)
PURE Bioscience Reports Fiscal First Quarter 2022 Financial Results Business Wire - Wed Dec 15, 2021

PURE Bioscience, Inc. ( OTCQB: PURE ) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0600 (-7.69%)
PURE Bioscience Reports Fiscal 2021 Financial Results Business Wire - Thu Oct 28, 2021

PURE Bioscience, Inc. ( OTCQB: PURE ) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...

PURE : 0.0600 (-7.69%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - 1 hour ago
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot